Cormorant Asset Management, LP, 10% Owner at Monte Rosa Therapeutics, Inc. (GLUE), bought 3,202,200 shares at $19.00 ($11.4M) on 2021-06-28, disclosed to the SEC on 2021-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,602,200 | $0 | 0.0% |
| 2 | $19.00 | 600,000 | $11.4M | 100.0% |
| Total | $3.56 avg | 3,202,200 | $11.4M | 100% |
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| EYPT | BUY | 2024-05-08 | $20.2M | — | Filing → |
| CRBP | BUY | 2024-02-06 | $14.3M | — | Filing → |